Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 116 trades.
If we consider the specifics of each trade, it is accurate to state that 43% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 25 are puts, for a total amount of $2,073,442 and 91, calls, for a total amount of $5,734,136.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $470.0 and $1300.0 for Eli Lilly, spanning the last three months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $470.0 to $1300.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 12/19/25 | $418.0 | $409.0 | $412.6 | $480.00 | $825.2K | 34 | 20 |
| LLY | PUT | SWEEP | NEUTRAL | 01/16/26 | $132.65 | $130.95 | $130.95 | $940.00 | $629.1K | 193 | 49 |
| LLY | CALL | SWEEP | BULLISH | 05/16/25 | $69.0 | $66.95 | $69.0 | $880.00 | $207.0K | 10 | 57 |
| LLY | CALL | SWEEP | BEARISH | 02/21/25 | $19.95 | $19.55 | $19.95 | $880.00 | $179.7K | 1.4K | 680 |
| LLY | PUT | SWEEP | BULLISH | 06/20/25 | $31.65 | $30.15 | $30.15 | $800.00 | $117.5K | 725 | 58 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Eli Lilly
- Trading volume stands at 4,662,591, with LLY's price up by 3.71%, positioned at $873.4.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 0 days.
Professional Analyst Ratings for Eli Lilly
3 market experts have recently issued ratings for this stock, with a consensus target price of $1066.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Eli Lilly, targeting a price of $1190. * An analyst from Wells Fargo has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $970. * Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Eli Lilly with a target price of $1038.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
